BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20149764)

  • 1. Determination and identification of estrogenic compounds generated with biosynthetic enzymes using hyphenated screening assays, high resolution mass spectrometry and off-line NMR.
    de Vlieger JS; Kolkman AJ; Ampt KA; Commandeur JN; Vermeulen NP; Kool J; Wijmenga SS; Niessen WM; Irth H; Honing M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):667-74. PubMed ID: 20149764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On-line formation, separation, and estrogen receptor affinity screening of cytochrome P450-derived metabolites of selective estrogen receptor modulators.
    van Liempd SM; Kool J; Niessen WM; van Elswijk DE; Irth H; Vermeulen NP
    Drug Metab Dispos; 2006 Sep; 34(9):1640-9. PubMed ID: 16790557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profiling of endocrine-disrupting compounds by on-line cytochrome p450 bioreaction coupled to on-line receptor affinity screening.
    Van Liempd SM; Kool J; Meerman JH; Irth H; Vermeulen NP
    Chem Res Toxicol; 2007 Dec; 20(12):1825-32. PubMed ID: 17975887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-dimensional turbulent flow chromatography coupled on-line to liquid chromatography-mass spectrometry for solution-based ligand screening against multiple proteins.
    Zhou JL; An JJ; Li P; Li HJ; Jiang Y; Cheng JF
    J Chromatogr A; 2009 Mar; 1216(12):2394-403. PubMed ID: 19203758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of an estradiol enzyme-linked immunosorbent assay kit, liquid chromatography-tandem mass spectrometry, and ultra performance liquid chromatography-quadrupole time of flight mass spectrometry for part-per-trillion analysis of estrogens in water samples.
    Farré M; Kuster M; Brix R; Rubio F; López de Alda MJ; Barceló D
    J Chromatogr A; 2007 Aug; 1160(1-2):166-75. PubMed ID: 17540393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Online magnetic bead dynamic protein-affinity selection coupled to LC-MS for the screening of pharmacologically active compounds.
    Jonker N; Kretschmer A; Kool J; Fernandez A; Kloos D; Krabbe JG; Lingeman H; Irth H
    Anal Chem; 2009 Jun; 81(11):4263-70. PubMed ID: 19476387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of norethindrone and ethinyl estradiol in human plasma by high performance liquid chromatography with tandem mass spectrometry--experiences on developing a highly selective method using derivatization reagent for enhancing sensitivity.
    Li W; Li YH; Li AC; Zhou S; Naidong W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Oct; 825(2):223-32. PubMed ID: 16213451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and estrogenic characterization of impurities in commercial bisphenol A diglycidyl ether (BADGE).
    Terasaki M; Kazama T; Shiraishi F; Makino M
    Chemosphere; 2006 Oct; 65(5):873-80. PubMed ID: 16631231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of aromatisation of the 3-keto-4-ene metabolite of tibolone to an estrogenic derivative.
    Raobaikady B; Parsons MF; Reed MJ; Purohit A
    Steroids; 2006 Jul; 71(7):639-46. PubMed ID: 16712888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated multiple ligand screening by frontal affinity chromatography-mass spectrometry (FAC-MS).
    Ng W; Dai JR; Slon-Usakiewicz JJ; Redden PR; Pasternak A; Reid N
    J Biomol Screen; 2007 Mar; 12(2):167-74. PubMed ID: 17218664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of LC-MS techniques and high-throughput approaches used to investigate drug metabolism by cytochrome P450s.
    Youdim KA; Saunders KC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1326-36. PubMed ID: 20207203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear magnetic resonance and liquid chromatography-mass spectrometry combined with an incompleted separation strategy for identifying the natural products in crude extract.
    Dai D; He J; Sun R; Zhang R; Aisa HA; Abliz Z
    Anal Chim Acta; 2009 Jan; 632(2):221-8. PubMed ID: 19110097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring ligand modulation of protein-protein interactions by mass spectrometry: estrogen receptor alpha-SRC1.
    Bovet C; Ruff M; Eiler S; Granger F; Wenzel R; Nazabal A; Moras D; Zenobi R
    Anal Chem; 2008 Oct; 80(20):7833-9. PubMed ID: 18778086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of cytochrome P450 BM3 mutants as biocatalysts for the profiling of estrogen receptor binding metabolites of the mycotoxin zearalenone.
    Reinen J; Kalma LL; Begheijn S; Heus F; Commandeur JN; Vermeulen NP
    Xenobiotica; 2011 Jan; 41(1):59-70. PubMed ID: 21087115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of metabolites in human hepatic bile using 800 MHz 1H NMR spectroscopy, HPLC-NMR/MS and UPLC-MS.
    Duarte IF; Legido-Quigley C; Parker DA; Swann JR; Spraul M; Braumann U; Gil AM; Holmes E; Nicholson JK; Murphy GM; Vilca-Melendez H; Heaton N; Lindon JC
    Mol Biosyst; 2009 Feb; 5(2):180-90. PubMed ID: 19156264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of liquid chromatography-two-dimensional nuclear magnetic resonance spectroscopy using pre-concentration column trapping and liquid chromatography-mass spectrometry for the identification of degradation products in stressed commercial amlodipine maleate tablets.
    Murakami T; Fukutsu N; Kondo J; Kawasaki T; Kusu F
    J Chromatogr A; 2008 Feb; 1181(1-2):67-76. PubMed ID: 18191867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug screening of pharmaceutical discovery compounds by micro-size exclusion chromatography/mass spectrometry.
    Wabnitz PA; Loo JA
    Rapid Commun Mass Spectrom; 2002; 16(2):85-91. PubMed ID: 11754252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of estrogens and progestogens by mass spectrometric techniques (GC/MS, LC/MS and LC/MS/MS).
    Díaz-Cruz MS; López de Alda MJ; López R; Barceló D
    J Mass Spectrom; 2003 Sep; 38(9):917-23. PubMed ID: 14505318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.